BIOMAT Database Logo BIOMAT Database Logo

IgA deficiency during penicillamine treatment. 1977

R D Forrest, and H Boström, and P A Dahlberg

UI MeSH Term Description Entries
D007070 Immunoglobulin A Represents 15-20% of the human serum immunoglobulins, mostly as the 4-chain polymer in humans or dimer in other mammals. Secretory IgA (IMMUNOGLOBULIN A, SECRETORY) is the main immunoglobulin in secretions. IgA,IgA Antibody,IgA1,IgA2,Antibody, IgA
D007153 Immunologic Deficiency Syndromes Syndromes in which there is a deficiency or defect in the mechanisms of immunity, either cellular or humoral. Antibody Deficiency Syndrome,Deficiency Syndrome, Immunologic,Deficiency Syndromes, Antibody,Deficiency Syndromes, Immunologic,Immunologic Deficiency Syndrome,Immunological Deficiency Syndromes,Antibody Deficiency Syndromes,Deficiency Syndrome, Antibody,Deficiency Syndrome, Immunological,Deficiency Syndromes, Immunological,Immunological Deficiency Syndrome,Syndrome, Antibody Deficiency,Syndrome, Immunologic Deficiency,Syndrome, Immunological Deficiency,Syndromes, Antibody Deficiency,Syndromes, Immunologic Deficiency,Syndromes, Immunological Deficiency
D010396 Penicillamine 3-Mercapto-D-valine. The most characteristic degradation product of the penicillin antibiotics. It is used as an antirheumatic and as a chelating agent in Wilson's disease. Dimethylcysteine,Mercaptovaline,beta,beta-Dimethylcysteine,Copper Penicillaminate,Cuprenil,Cuprimine,D-3-Mercaptovaline,D-Penicillamine,Metalcaptase,D 3 Mercaptovaline,D Penicillamine,Penicillaminate, Copper,beta,beta Dimethylcysteine
D004406 Dysgammaglobulinemia An immunologic deficiency state characterized by selective deficiencies of one or more, but not all, classes of immunoglobulins. Dysgammaglobulinemias
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

R D Forrest, and H Boström, and P A Dahlberg
IgA deficiency during D-penicillamine treatment.
February 1977, British medical journal,
R D Forrest, and H Boström, and P A Dahlberg
[Immune deficiency during D-penicillamine treatment ].
November 1977, La Nouvelle presse medicale,
R D Forrest, and H Boström, and P A Dahlberg
D-penicillamine-induced IgA deficiency in Wilson's disease.
October 1976, Lancet (London, England),
R D Forrest, and H Boström, and P A Dahlberg
IgA deficiency during aurothioglucose treatment. A case report.
January 1984, Scandinavian journal of rheumatology,
R D Forrest, and H Boström, and P A Dahlberg
[D-penicillamine-induced IgA deficiency in the therapy of Wilson's disease].
January 1990, Klinische Padiatrie,
R D Forrest, and H Boström, and P A Dahlberg
IgA deficiency during treatment of infantile hypothyroidism with thyroxine.
May 1984, British medical journal (Clinical research ed.),
R D Forrest, and H Boström, and P A Dahlberg
Myasthenia syndrome during penicillamine treatment.
June 1975, British medical journal,
R D Forrest, and H Boström, and P A Dahlberg
Selective IgA deficiency developed during treatment of scleroderma kidney with captopril.
April 1988, The Journal of rheumatology,
R D Forrest, and H Boström, and P A Dahlberg
Thymopentin treatment of selective IgA deficiency.
January 1985, Survey of immunologic research,
R D Forrest, and H Boström, and P A Dahlberg
IgA deficiency, epilepsy, and phenytoin treatment.
October 1975, Lancet (London, England),
Copied contents to your clipboard!